Weight Loss Medication Titration via Unit Dosage Packages

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing pharmaceutical treatments for obesity and related conditions often incur adverse side effects when administered at full dosage, leading to intolerance and premature abandonment of treatment programs.

Innovation Solution

A method involving the gradual increase of one drug's dosage in a multi-component formulation from an initial low dose to an effective maintenance dose, reducing side effects and enhancing patient compliance and treatment efficacy, using unit dosage packages that contain varying amounts of drugs such as bupropion, zonisamide, and naltrexone.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If full dosage of weight loss medication is administered, then treatment efficacy is improved, but adverse side effects increase

Engineering Contradiction:
Improvetreatment efficacyVSAvoidadverse side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by implementing a titration schedule where the medication dosage is gradually increased over time before reaching the full effective dose. The method starts with an initial lower dosage and progressively increases it to the target dosage over multiple dosing intervals, allowing the patient's body to acclimate to the medication and reducing the likelihood of severe adverse side effects while still achieving treatment efficacy.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent applies dynamics by making the dosage adjustable and flexible rather than fixed. The method allows healthcare providers to modify the dosing schedule based on patient response and tolerance, transitioning from a static full dosage approach to a dynamic titration approach where the dosage adapts to the individual patient's needs and tolerance levels.

Inventive Principle:
Principle #15Dynamics

2Reliability

If full dosage is administered immediately, then treatment effectiveness is enhanced, but patient compliance decreases due to intolerance

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidpatient compliance
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent applies preliminary action by implementing a titration schedule where the medication dosage is gradually increased over time before reaching the full effective dose. The method starts with an initial lower dosage and progressively increases it to the target dosage over multiple dosing intervals, allowing the patient's body to acclimate to the medication and reducing the likelihood of severe adverse side effects while still achieving treatment efficacy.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent applies parameter changes by modifying the dosage parameter over time rather than maintaining a constant full dosage. The method systematically changes the dosage parameter through a predefined titration schedule, adjusting the amount of medication administered at each dosing interval to reach the target dosage gradually, thereby improving patient compliance while maintaining effectiveness.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If combination of multiple drugs is administered, then weight loss ability is enhanced, but initial adverse side effects are not reduced

Engineering Contradiction:
Improveweight loss abilityVSAvoidinitial adverse side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by implementing a titration schedule where the medication dosage is gradually increased over time before reaching the full effective dose. The method starts with an initial lower dosage and progressively increases it to the target dosage over multiple dosing intervals, allowing the patient's body to acclimate to the medication and reducing the likelihood of severe adverse side effects while still achieving treatment efficacy.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent applies partial action by initially administering a partial (lower) dosage of the medication combination rather than the full effective dose. This partial dosage approach allows the patient to tolerate the medication better initially, and the dosage is gradually increased to the full effective amount over time, balancing the need for weight loss efficacy with the need to minimize initial adverse side effects.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS20240366513A1Methods For Administering Weight Loss Medications
Publication Date: 2024.11.07 NALPROPION PHARMACEUTICALS LLC
  • US20240366513A1 patent drawing
  • US20240366513A1 patent drawing
  • US20240366513A1 patent drawing

AI summary

Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications.